SCHEMBL17433433

SCHEMBL17433433

COC(=O)c1cc(Br)cc2[nH]c(/C=C/c3ccc(Cl)cc3)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 6/20 0.46
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
PTGS2 P35354 2/20 0.41
MAPT P10636 2/20 0.40
HTT P42858 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
STAT3 P40763 1/20 0.39
POLB P06746 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
ALOX12 P18054 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38
MCL1 Q07820 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PTPN1 P18031 2/20 0.37
PTPN2 P17706 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17422743 0.86 F7 (0.43) KDM4EALDH1A1HPGDMAPTSTAT3
SCHEMBL17422745 0.86 F7 (0.43) KDM4EALDH1A1HPGDMAPTSTAT3
SCHEMBL18851007 0.84 ALDH1A1 (0.42) KDM4EALDH1A1HPGDPTGS2MAPT
SCHEMBL20545086 0.84 ALDH1A1 (0.42) KDM4EALDH1A1HPGDPTGS2MAPT
SCHEMBL18851306 0.78 KMT2A (0.50) KDM4EALDH1A1HPGDHTTTDP1
SCHEMBL20545630 0.78 KMT2A (0.50) KDM4EALDH1A1HPGDHTTTDP1
SCHEMBL18851499 0.78 ALOX5 (0.42) KDM4EALDH1A1HPGDPTGS2MAPT
SCHEMBL17422840 0.75 MAPT (0.45) NR4A2KDM4EALDH1A1HPGDPTGS2
SCHEMBL17422841 0.75 MAPT (0.45) NR4A2KDM4EALDH1A1HPGDPTGS2
SCHEMBL17433459 0.73 NR4A2 (0.50) NR4A2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2017-08-03 US disclosed
WO-2017075694-A1 ANTIBIOTIC COMPOUNDS, PHARMACEUTICAL FORMULATIONS THEREOF AND METHODS AND USES THEREFOR SIMON FRASER UNIVERSITY (CA) 2017-05-11 WO disclosed
WO-2016004513-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS SIMON FRASER UNIVERSITY (CA) 2016-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216252-A1 ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS PDK1, PDK3, PDK2 NR4A2 3468/4885KDM4E 1649/4885ALDH1A1 2424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.